Worth Asset Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Worth Asset Management’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13	Closed	-$2.67K	–	275
2023 Q2	$2.67K	Hold	13	–	–	﹤0.01%	388
2023 Q1	$1.31K	Hold	13	–	–	﹤0.01%	433
2022 Q4	$2.04K	Hold	13	–	–	﹤0.01%	407
2022 Q3	$3K	Hold	13	–	–	﹤0.01%	390
2022 Q2	$4K	Hold	13	–	–	﹤0.01%	430
2022 Q1	$3K	Buy	+13	New	+$2.86K	﹤0.01%	446

Other funds holding LYRA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Worth Asset Management's LYRA Position: Q3 2023 in Review

Worth Asset Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2023, closing a stake of 13 shares — an estimated $2.67K sold.

Worth Asset Management first reported a position in LYRA in Q1 2022 and held it in 6 quarters. The position peaked at $4K in Q2 2022. 44 funds tracked by Wall St. Rank hold LYRA as of Q3 2023.

Worth Asset Management reported no remaining LYRA THERAPEUTICS INC position as of Q3 2023 after selling out during the quarter.
Worth Asset Management sold 13 LYRA THERAPEUTICS INC shares in Q3 2023, an estimated $2.67K.
Worth Asset Management first reported a position in LYRA THERAPEUTICS INC in Q1 2022 and held it in 6 quarters.
Worth Asset Management's LYRA THERAPEUTICS INC position peaked at $4K in Q2 2022.
44 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.